The America Psychiatric Association (APA) advocated against mandatory neuropsychological testing in the 2016 ECT device reclassification.
This spring, Life After ECT launched a comprehensive FDA reporting guide for injured electroconvulsive therapy (ECT) recipients. This post is a progress update and an overview of our future reporting goals.
Moira Dolan MD to the FDA regarding ECT draft guidance for the 2016 electroshock device risk reclassifacation.
ECT Device Safety - New York Association of Psychiatric Rehabilitation Services (NYAPRS) to the FDA, 2010
It's important to report unexpected ECT side effects to the FDA. Our guide will show you how using MedWatch.
These are reports from people who had ECT in recent years and experienced permanent deficits in memory ability and other cognitive abilities (known as anterograde amnesia).